Introduction
Interleukin (IL)-21, the most recently described member of the common gamma-chain cytokine family, is found to be a potent immunoregulatory cytokine 1 . This cytokine is produced by activated CD4 + T cells and targets several immune cells [2] [3] [4] [5] including NK cells 3, 4, [6] [7] [8] , dendritic cells, CTLs 3,4,9 as well as B cells [10] [11] [12] [13] . Structurally, IL-21 is considered to be a member of the type-I-cytokine family, which includes IL-2, IL-4 and IL-15 2, [14] [15] [16] . The receptors for all these type I cytokines contain the common gamma-chain 2, [14] [15] [16] . In leukocytes, type-I cytokines activate the Janus family tyrosine kinases, JAK1 and JAK3 2 , which in turn regulate activation of signal transducer and activator of transcription 1 (Stat1), Stat3 and, 20 . This activation of Stats is cell-type specific. Interestingly, in endothelial cells, Stat3 phosphorylation has been associated with induction of angiogenesis 21, 22 . Recent studies suggest that IL-21 can be used as an immunomodulatory compound 23, 24 , and its use in the clinical setting is underway 25 .
The process of new blood vessel formation or angiogenesis is essential for tumor growth and metastasis, as it is critical for supply of oxygen and nutrients. Inhibition of angiogenesis is therefore a promising strategy for treatment of cancer 26, 27 . Several antiangiogenesis compounds have been developed and tested based on their ability to inhibit proangiogenic growth factors such as VEGF [SU6668, SU11248 and bevacizumab [28] [29] [30] ] or intervention in signal transduction in endothelial cells directly [TNP-470, endostatin and anginex [31] [32] [33] [34] ]. Members of the type-I-cytokine family, i.e. IL-2, -4, are suggested to affect the formation of new blood vessels [35] [36] [37] , but their ability to block angiogenesis has not been carefully tested. In analogy to IL-2 and IL-4, we hypothesized that IL-21 inhibits angiogenesis and thus mediates anti-tumor efficacy partly due to its effects on endothelial growth and sprouting. These properties along with its ability to regulate various immune cells endow IL-21 with the potent ability to promote tumor regression. 
Material and Methods

Cell culture and reagents
The murine EC cell line SVEC4-10 and TME were purchased from ATCC and cultured in DMEM (Gibco Invitrogen, Breda, The Netherlands) supplemented with 10% FCS (Hyclone Perbio Science, Erembodegem-Aalst, Belgium), 2mM HEPES and 2mM Lglutamine (Gibco) in 0.2% gelatine (Sigma, Zwijndrecht, the Netherlands) coated tissue culture flasks (Costar Corp., Cambridge, MA). The cells were subcultured 1:10. Human umbilical vein derived endothelial cells (HUVEC) were cultured as described previously 31 .
Angiogenic stimulation of the ECs was induced by 10ng/ml bFGF and/or 40ng/ml VEGF (Peprotech, London, United Kingdom). Primary mouse endothelial cells we isolated as described earlier 38 . Normal haert tissues derived from C57Bl/6 mice were mechanically and enzymatically digested. The obtained single cell suspensions were allowed to adhere to gelatin coated tissue culture flasks (Costar Corp. supplemented with 10% FCS (Perbio Science), 25mM Hepes buffer, 2mM L-glutamine, 100U
/ml Penicillin, 100μg/ml Streptomycin, 1mM sodium pyruvate, 1x non-essential amino acids and 50μM 2-mercaptoethanol (all Gibco). Cells were maintained with addition of 40μg/ml G418. Before injection in mice, G418 concentration was increased to 400μg/ml for two rounds of expansion.
Recombinant mouse IL-21 protein was obtained as previously described 40 .
Recombinant mouse IL-2 was obtained from R&D systems (Minneapolis, MN). Anginex was kindly provided by Dr. K. Mayo (Department of Biochemistry, Minnesota, Minneapolis, MN).
In vitro and ex vivo sprouting assay
In vitro sprouting and tube formation was studied using Cytodex-3 beads overgrown with SVEC4-10 endothelial cells in a three-dimensional collagen gel (PureCol, INAMED biomaterials, Fremont, CA) containing 10 ng/ml bFGF as described previously 41 . Sprout formation was stimulated with medium containing 10 ng/ml bFGF and 40ng/ml VEGF.
Recombinant IL-21, IL-2 or anginex were added in the medium on top of the gel. After 72 hours the length of the sprouts was analyzed.
Ex vivo sprouting was investigated by using rings of the mouse thoracic aorta as was described earlier 34 . 1-mm-thick cross-sectional rings were placed in the wells of a 96-well tissue culture plate in the previous described collagen gel. Medium (DMEM, 20% FCS, 2 mM L-glutamine, 2 mM sodiumpyruvate, 20 mM HEPES, 1% nonessential amino acids, 1.5%
MEM vitamins, antibiotics, 1 IU/100 ml heparin (Gibco Invitrogen, Breda, The Netherlands)
containing recombinant IL-21, IL-2 or anginex was put on top of the gels. Vascular sprouting from each ring was examined using an inverted microscope. The width of the tube formation area was measured at three different predefined places of the aortic ring. Different culture conditions were tested at least in triplicate.
Flow cytometry
Endothelial cells were fixed with 1% PFA for 30min at room temperature. IL-21 receptor α (IL21-Rα) expression was detected biotinylated mAb to IL-21Rα 10 . Subsequently the cell suspensions were incubated with phycoerithrine labeled strepdavidine (DAKO, Glostrup, Denmark). Stained cells were analyzed on a FACSscan flow cytometer using Cell Quest software (Becton Dickinson, Sunnyvale, CA).
Proliferation and apoptosis measurement
Endothelial cell proliferation was measured using a [ 3 H]thymidine (Amersham Life Science, Roosendaal, The Netherlands) incorporation assay as described previously 41 .
Angiogenically stimulated SVEC4-10 were exposed for 3 days to recombinant mouse IL-21, IL-2 or anginex before proliferation was assessed. At least three independent experiments were performed. In each experiment measurements were done in triplicate.
Apoptosis was measured by propidium iodide (PI) (Brunschwig Chemie,Amsterdam,
The Netherlands) staining as described previously 41 . bFGF (10 ng/ml) stimulated cells were cultured for 3 days in the presence or absence of IL-21, IL-2 or anginex. After this period, the cells were harvested, fixed in 70% ethanol, centrifuged, resuspended in DNA extraction buffer and incubated for 20' at 37°C. After incubation, PI was added at a final concentration of 20 μg/ml, and the DNA profile was directly analyzed with the FACScalibur.
Migration measurement
Migration of murine endothelial cells was measured using the wound assay 34 . In brief, SVEC4-10 cells were seeded in gelatin-coated cell culture plates (Costar Corp., Cambridge, MA) and grown to confluence. Using a blunt pipette tip, a cross-shaped wound was made in the well. Cells were washed with PBS and fresh medium containing 10 ng/ml bFGF with or without IL-21, IL-2 or anginex. Wound width was measured at four predefined locations at start and at 2, 4, 6, 8, and 24 hours after wounding.
Chorioallantoic membrane assay (CAM)
The chorioallantoic membrane (CAM) assay was performed in fertilized White
Leghorn eggs as described previously 41 . In brief, CAMs were treated by daily addition of sterile PBS, recombinant mouse IL-21 or IL-2 from days 10 to 13. On day 14, the CAMs were photographed. Quantification of vascularization was done by enumeration of intersections with five concentric rings that were superimposed on the photographs.
Mouse tumor model
C57Bl/6 mice were injected subcutaneously at the base of the spine with 5x10 Netherlands) primary antibody for 1hour, followed by incubation with peroxidase labeled goat anti-rat IgG antibody (Immunotech, Marseille, France). The peroxidase activity was detected using diaminobenzidine (DAB; Sigma, Zwijndrecht, The Netherlands).
Quantitative real time RT-PCR (qRT-PCR)
Total RNA isolation from cultured cells, cDNA synthesis and quantitative real-time RT-PCR were performed essentially as described previously 42 
Statistic analysis
All data are expressed with standard error of the mean (SEM) and were statistically analyzed using Mann-Whitney U tests (using SPSS-10 software). Probabilities below 0.05
were considered statistically significant.
Results
IL-21 inhibits sprout formation by EC
The sprouting of primary aortic EC into a 3-dimensional semi-natural collagen matrix was inhibited by approximately 60% in the presence of IL-21 (200 ng/ml, Figure 1A Next to proliferation, migration of endothelial cells is a key process in the formation of new blood vessels during angiogenesis. EC migration was investigated using the wound assay. While anginex inhibited the wound closure efficiently, IL-21 as well as IL-2 did not have an effect. It is concluded that IL-21 does not affect migration of EC ( Figure 3B ).
IL-21 and IL-2 affect in vivo angiogenesis in the chick embryo chorioallantoic membrane (CAM) assay
In vivo angiogenesis was first investigated in the chorioallantoic membrane (CAM) of the chicken embryo, an assay that represents developmental angiogenesis. Although treatment of the CAMs with IL-21 did not reduce vessel density ( Figure 4B ), a disturbed, tortuous and irregular growth of vessels was detected as compared to control CAMs ( Figure 4A ).
Recombinant IL-2 showed a similarly disturbed vessel outgrowth. In addition, IL-2 did reduce vessel density in the CAMs by 25% ( Figure 4A, B) . This response to IL-2 confirms results presented in earlier reports 36 .
IL-21 inhibits tumor angiogenesis in vivo
Effects of IL-21 and IL-2 on tumor angiogenesis in vivo were determined by treatment of EG7 tumor bearing mice with IL-21, IL-2 or PBS (control) at concentrations that have previously been shown to be effective ( Figure 4C ) 40 . Immunohistochemical staining of tumor sections of mice treated with recombinant mouse IL-21 using CD31 antibody showed a significantly decreased microvessel density, as compared to PBS treated mice ( Figure 4C, D) .
Treatment of mice with IL-2 showed a decreased vessel formation in tumors as well, but this inhibition was not found to be statistically significant ( Figure 4C, D) .
IL-21 and IL-2 regulate expression of angiogenesis-related genes in activated EC
In order to investigate the feature of the angiostatic response of EC after exposure to and IL-2. In tumor tissues of mice treated with IL-21 we also observed a significant decrease of VEGFA and both receptors VEGFR1, and -2, as compared to PBS treatment ( Figure 5D ).
The mRNA expression of angiopoietins is also reduced upon IL-21 treatment ( Figure 5E ), though only significantly for angiopoietin-2. A significant decline of approximately 75% is determined for TIE1 and TIE2 expression in tumor tissues of IL-21 treated mice ( Figure 5F ).
In experiments treatment with IL-2 did never induce significant changes of expression.
Regulation of Stat phosphorylation in EC after IL-21 treatment
In Angiopoietins and their receptors are essential for vessel sprouting, remodeling and maturation 44 . A decrease of their expression might interfere with these processes during angiogenesis. This is also in line with our observations in the CAM assay that showed a disturbed and tortuous character of the vessels after IL-21 treatment. Interestingly, IL-21 also decreases the expression of VEGFR1 in EC. This is also consistent with the observed inhibition of sprouting and disturbed vessel morphology because a defect in VEGFR1 can lead to the assembly of endothelial cells into abnormal vascular channels 45 . However we could detect irregular vessel morphology in the CAMs after IL-2 treatment as well, indicating that other factors, e.g. nitric oxide 36 , might be involved in the disturbed vessel outgrowth in
CAMs as well. These data suggest that IL-2 is likely to be involved in survival rather than in differentiation mechanisms, which IL-21 seems to be. [48] [49] [50] . Our data suggest that inhibition of Stat3 could also inhibit tumor angiogenesis by a direct effect on endothelial cells.
In conclusion, the ability of IL-21 to inhibit angiogenesis in vitro and in vivo, in combination with its previously reported beneficial effect on survival of tumor bearing mice 40 
